NCT01870245终止1 期
A Phase 1 Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 Administered Intravenously to Healthy Volunteers
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 入组人数
- 4
- 试验地点
- 1
- 主要终点
- Frequency of AEs
研究概览
简要总结
This is a randomized, double-blind, placebo-controlled, multiple-dose study, designed to assess the safety, tolerability, and pharmacokinetics (PK) of ACHN-975. This study will take place in the US at one clinical site.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Body weight between 40 and 100 kilograms (between ~88 pounds and ~220 pounds)
- •Use of contraception
- •Stable health
- •Negative tests for alcohol, tobacco, and drugs of abuse
排除标准
- •History of clinically significant disease
- •Pregnancy
研究组 & 干预措施
ACHN-975
Experimental
干预措施: ACHN-975 (Drug)
Placebo
Placebo Comparator
干预措施: placebo (Drug)
结局指标
主要结局
Frequency of AEs
时间窗: 28 days
Severity of AEs
时间窗: 28 days
次要结局
- Plasma concentrations of ACHN-975(16 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese SubjectsHealthy ParticipantsNCT06506591Zhejiang Wenda Medical Technology Co., Ltd.106
已完成
1 期
A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic PatientsType 2 Diabetic PatientsNCT03006159Jiangsu HengRui Medicine Co., Ltd.36
Unknown
1 期
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral HRS5685 in Healthy SubjectsHuman Immunodeficiency Virus-1 (HIV-1) InfectionNCT05328583RetroLead (Shanghai) BioPharma Co., Ltd.64
终止
1 期
Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive ImpairmentMild Cognitive ImpairmentAlzheimer's DiseaseNCT02573740AbbVie8
已完成
1 期
A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK39297 in Healthy SubjectsHealthyNCT06350279Haisco Pharmaceutical Group Co., Ltd.96